-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906. Outcomes Research—Malignant Conditions (Myeloid Disease): Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, AML, Biological, survivorship, Diseases, Lymphoma (any), CMML, Elderly, Therapies, MDS, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , transfusion
Monday, December 7, 2020: 7:00 AM-3:30 PM

Saaya Tsutsué1*, Takahiro Suzuki2, Hyojin Kim3*, William YuanHao Kuan3* and Bruce Crawford3*

1HEOR, Celgene K.K., a Bristol-Myers Squibb Company, Tokyo, Japan
2Division of Hematology, Department of Medicine, Kitasato University School of Medicine, Kanagawa, Japan
3Syneos Health, Tokyo, Japan

Gabriela Sanchez-Petitto, MD1, Olga Goloubeva, PhD, MSc2*, James Childress, MD3*, Tahreem Iqbal, MD3*, Jack Masur, MD3*, Max An, BS4*, Safwan Muhammad, MD3*, Justin Lawson, PharmD BCOP1*, Jasmin Sahbaz, MD5*, Brian Barr, MD4,5*, Vu H. Duong, MD1,4, Jennie Y. Law, MD1,4,6, Ashkan Emadi, M.D., Ph.D.1,7, Maria R. Baer, M.D.2,6,8 and Sandrine Niyongere, MD1,4

1Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
2University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
3Department of Internal Medicine, University of Maryland, Baltimore
4University of Maryland School of Medicine, Baltimore, MD
5Division of Cardiology, University of Maryland, Baltimore, MD
6Veterans Affairs Medical Center, Baltimore, MD
7Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
8Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD

Tommi Tervonen1,2*, Katelyn Cutts3*, Jaein Seo3*, Salem Abi Nehme4*, Ignazia La Torre4*, Thibaud Prawitz1*, Clara Chen4*, CL Beach4* and Jenny Wang4*

1Evidera, London, United Kingdom
2University Medical Center Groningen, Groningen, Netherlands
3Evidera, Bethesda, MD
4Bristol Myers Squibb, Princeton, NJ

Larysa Sanchez, MD1*, Xavier Leleu, MD2, Jennifer Beaumont3*, Hailin Yu3*, Stacie Hudgens, MA3*, Holger W Auner, MD, PhD4, Hang Quach, MD5, Sosana Delimpasi, MD6*, Ivan Spicka, MD, PhD7*, Luděk Pour, MD8*, Meletios A Dimopoulos9, Halyna Pylypenko, MD10*, Vadim A Doronin, MD11*, Ganna Usenko, MD12*, Roman Hajek, MD, PhD13, Reuben Benjamin, MD14, Christopher P. Venner, MD15, Mamta Garg, MD, FRCP, FRCPath16*, Don A. Stevens, MD17, Sundar Jagannath, MD18*, Philippe Moreau19*, Moshe Levy, MD20*, Nizar Bahlis, MD21, Thierry Facon, MD22*, Yi Chai23*, Xiwen Ma23*, Shijie Tang23*, Hoyee Leong23*, Jatin J. Shah, MD23*, Sharon Shacham, PhD, MBA23*, Michael G Kauffman, MD, PhD23, Paul G. Richardson, MD24 and Sebastian Grosicki, MD, PhD25

1Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York
2CHU de Poitiers - Hôpital La Milétrie, Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, POITIERS, France
3Clinical Outcomes Solutions, Tucson, AZ
4Imperial College Healthcare NHS Trust, London, United Kingdom
5St. Vincent’s Hospital, Fitzroy, VIC, Australia
6Hematology/Lymphomas and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
71st Internal Clinic - Clinic of Hematology, General University Hospital, Prague, Czech Republic
8Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
9Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
10Regional Treatment and Diagnostic Hematology Center, Cherkassy Regional Oncology Dispensary of Cherkasy Regional Council, Cherkassy, Ukraine
11Hematology Department, State Budget Healthcare Institution of Moscow, City Clinical Hospital #40 of Moscow Healthcare Department, Moscow, Russian Federation
12City Clinical Hospital No. 4 of Dnipro City Council, City Hematology Center, Dnipro, Ukraine
13Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
14Kings College Hospital NHS Foundation Trust, London, United Kingdom
15Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
16University Hospitals Leicester NHS Trust, Leicester, United Kingdom
17Norton Cancer Institute - St Matthews Campus, Louisville, KY
18Icahn School of Medicine at Mount Sinai, New York, NY
19CHU Hotel-Dieu, Nantes, France
20Baylor University Medical Center, Dallas, TX
21University of Calgary, Charbonneau Cancer Institute, Calgary, AB, Canada
22CHU Lille, Service des Maladies du Sang F-59000, Lille, France
23Karyopharm Therapeutics, Newton, MA
24Dana-Farber Cancer Institute, Boston, MA
25Clinical Department of Hematology and Prophylaxis of Cancer Diseases, Independent Public Healthcare Facility Municipal Hospital Group, Chórzow, Poland

Jodi J Lipof, MD1, Dharmini Manogna, MD2, Andrea M. Baran, MS3*, Bassil Said, MD4*, Michael W. Becker, MD1, Jason H. Mendler, MD, PhD1, Omar S. Aljitawi, MD1, Kristen Marie O'Dwyer, MD5, Eric Huselton, MD6, Richard Burack, MD, PhD7, Margaret Blaney1*, Taylor Douglas1*, Jane L. Liesveld, MD3 and Melissa Loh, MBBCHBAO1

1Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
2Division of Internal Medicine, Rochester General Hospital, Rochester, NY
3Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
4Internal Medicine, Rochester General Hospital, Rochester, NY
5University of Rochester Medical Center, Rochester, NY
6Division of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY
7Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY

Melissa Loh, MBBCHBAO1, Mazie Tsang, MD2, Thomas W. Leblanc3, Anthony Back, MD4*, Paul Duberstein, PhD5*, Supriya G. Mohile, MD, MS1*, Ronald Epstein, MD6*, Heidi D. Klepin, MD7, Michael W. Becker, MD1, Areej El-Jawahri, MD8 and Stephanie J. Lee, MD, MPH9

1Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
2Hematology/Oncology, UCSF, San Francisco, CA
3Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
4University of Washington, Seattle, WA
5Department of Psychiatry, University of Rochester Medical Center, Rochester, NY
6University of Rochester Medical Center, ROCHESTER, NY
7Wake Forest University School of Medicine, Winston Salem, NC
8Massachusetts General Hospital / Harvard Medical School, Allston, MA
9Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Shaloo Gupta1*, Thomas Schroeder2*, Austin G Kulasekararaj, MD, MBBS, MRCP, FRCPath3, Halley Costantino1*, Jay Grisolano1*, Jackson Tang4*, Shalon Jones4* and Derek Tang4*

1Kantar, New York, NY
2Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany
3King's College Hospital - NHS Foundation Trust, NIHR Wellcome King’s Clinical Research Facility, London and King’s College London, London, United Kingdom
4Bristol Myers Squibb, Princeton, NJ

Hermioni L. Amonoo, MD1,2,3*, Areej El-Jawahri, MD2,4, Thomas W. LeBlanc, MD, MA, MS5, Alison R. Kavanaugh, NP2,6*, Jason A. Webb, MD5*, Lara Traeger, Ph.D.2,6*, Annemarie D. Jagielo, BA6*, Dagny M. Vaughn, MS6*, Madeleine Elyze, BA6*, Regina M. Longley, BA6*, Amir T. Fathi2,6, Gabriela S. Hobbs, MD2,6, Andrew M. Brunner2,6*, Nina R. O’Connor, MD7*, Selina M. Luger, MD, FRCPC8, Jillian Gustin, MD9*, Bhavana Bhatnagar, DO10 and Nora K. Horick, MS2,6*

1Dana-Farber Cancer Institute, Boston, MA
2Harvard Medical School, Boston, MA
3Brigham and Women's Hospital, Boston, MA
4Massachusetts General Hospital / Harvard Medical School, Allston, MA
5Duke University School of Medicine, Durham, NC
6Massachusetts General Hospital, Boston, MA
7University of Pennsylvania, Philadelphia, PA
8Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
9Palliative Medicine, The Ohio State University, Columbus, OH
10Hematology, The Ohio State University, Columbus, OH

*signifies non-member of ASH